Recognition and management of acute relapse of multiple sclerosis, neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease.
Sep 2026· Cell Death and Differentiation· 0 citations· 164 references
Medicine
TL;DR
The clinical patterns of acute attacks and relapses of multiple sclerosis, NMOSD and MOGAD are discussed, including the clinical and para-clinical modalities that are critical for timely recognition and diagnosis, and available evidence regarding treatment selection and responsiveness is presented.
Multiple Sclerosis (MS) is a chronic immune-mediated neurodegenerative disorder of the Central Nervous System (CNS) that affects more than 2.8 million people worldwide. It is recognized as one of the leading causes of non-traumatic neurological disability among young adults. It is an inflammatory demyelination disease...
K. Ravi, K. Arora· Current Neurovascular Resear...· 0 citations
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) has emerged as a distinct inflammatory demyelinating disorder of the central nervous system. Although relatively rare, growing recognition of this entity has highlighted important differences from multiple sclerosis and neuromyelitis optica spectru...
Kavya Rajanna, G. Sharma· International Journal of Con...· 0 citations
Importance
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a demyelinating disease distinct from multiple sclerosis (MS) and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4+NMOSD). Magnetic resonance imaging (MRI) is central to confirming attacks, defining lesion di...
Eoin P. Flanagan, Brenda L. Banwell, Laura Cacciaguerra et al.· JAMA Neurology· 0 citations
Four clinical cases of NMOSD that illustrate the difficulties in making a timely diagnosis due to an ambiguous clinical, radiological and laboratory picture were presented and strategies to improve the early diagnosis of NMOSD to prevent such outcomes were proposed.
K. Bakhtiyarova, O. V. Lyutov, T. R. Galiullin et al.· Neurology, neuropsychiatry,...· 0 citations
The clinical presentation, characteristic MRI findings, and positive oligoclonal bands supported the diagnosis of multiple sclerosis and the patient was diagnosed with multiple sclerosis and treated with intravenous methylprednisolone and azathioprine as maintenance.
Nicholas Ciarico, K. Yoesdyanto, Iglesias Owen· Lumina· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.